Obesity-like metabolic effects of high-carbohydrate or high-fat diets consumption in metabolic and renal functions

References

• Adabimohazab, R., et al., 2016. Does inflammation mediate the association between obesity and insulin resistance? Inflammation, 39 (3), 994–1003.
   PubMed Web of Science ®Google Scholar
• Akasheh, R.T., et al., 2013. New pathways to control inflammatory responses in adipose tissue. Current opinion in pharmacology, 13 (4), 613–617.
   PubMed Web of Science ®Google Scholar
• Alam, M.A., Kauter, K., and Brown, L., 2013. Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients, 5 (3), 637–650.
   PubMed Web of Science ®Google Scholar
• Araújo, E.P., et al., 2007. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology, 148 (12), 5991–5997.
   PubMed Web of Science ®Google Scholar
• Balbi, A.P.C., et al., 2008. MAPK and angiotensin II receptor in kidney of newborn rats from losartan-treated dams. Pediatric nephrology, 23 (9), 1433–1444.
   PubMed Web of Science ®Google Scholar
• Barbieri, D., et al., 2019. Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1. Clinical kidney journal, 12 (3), 420–426.
   PubMed Web of Science ®Google Scholar
• Börgeson, E. and Sharma, K., 2013. Obesity, immunomodulation and chronic kidney disease. Current opinion in pharmacology, 13 (4), 618–624.
   PubMed Web of Science ®Google Scholar
• Bruggeman, L.A., et al., 2011. TNFR2 interposes the proliferative and NF-ΚB-mediated inflammatory response by podocytes to TNF-α. Laboratory investigation; a journal of technical methods and pathology, 91 (3), 413–425.
   PubMed Web of Science ®Google Scholar
• Budny, A., et al., 2019. Obesity as a tumour development triggering factor. Annals of agricultural and environmental medicine, 26 (1), 13–23.
   PubMed Web of Science ®Google Scholar
• Burhans, M.S., et al., 2018. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Comprehensive physiology, 39, 1–58.
   Google Scholar
• Coelho, I., et al., 2012. Fish oil supplementation reduces cachexia and tumor growth while improving renal function in tumor-bearing rats. Lipids, 47 (11), 1031–1041.
   PubMed Web of Science ®Google Scholar
• Coelho, I., et al., 2016. Chronic fish oil supplementation partially reverses renal alterations in mice fed with a high-fat diet. Journal of functional foods, 26, 196–207.
   Web of Science ®Google Scholar
• Coimbra, T.M., et al., 2000. Early events leading to renal injury in obese Zucker (Fatty) rats with type II diabetes. Kidney international, 57 (1), 167–182.
   PubMed Web of Science ®Google Scholar
• Cook, H.T., 2010. The origin of renal fibroblasts and progression of kidney disease. The American journal of pathology, 176 (1), 22–24.
   PubMed Web of Science ®Google Scholar
• D’Agati, V.D., et al., 2016. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nature reviews. Nephrology, 12 (8), 453–471.
   PubMed Web of Science ®Google Scholar
• Declèves, A.-E. and Sharma, K., 2015. Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Current opinion in nephrology and hypertension, 24 (1), 28–36.
   PubMed Web of Science ®Google Scholar
• Dlamini, Z., et al., 2019. Regulation of alternative splicing in obesity-induced hypertension. Diabetes, metabolic syndrome and obesity: targets and therapy, 12, 1597–1615.
   PubMed Web of Science ®Google Scholar
• Ejerblad, E., et al., 2006. Obesity and risk for chronic renal failure. Journal of the American Society of Nephrology, 17 (6), 1695–1702.
   PubMed Web of Science ®Google Scholar
• Eknoyan, G., 2011. Obesity and chronic kidney disease. Nefrologia, 31 (4), 397–403.
   PubMed Web of Science ®Google Scholar
• Francescato, H.D.C., et al., 2007. Effect of JNK inhibition on cisplatin-induced renal damage. Nephrology, dialysis, transplantation, 22 (8), 2138–2148.
   PubMed Web of Science ®Google Scholar
• Gac, L., et al., 2015. Behavioral characterization of a model of differential susceptibility to obesity induced by standard and personalized cafeteria diet feeding. Physiology & behavior, 152 (A), 315–322.
   PubMedGoogle Scholar
• Gai, Z., et al., 2019. Lipid accumulation and chronic kidney disease. Nutrients, 11 (4), 722.
   PubMed Web of Science ®Google Scholar
• Gilbert, R.E. and Cooper, M.E., 1999. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney international, 56 (5), 1627–1637.
   PubMed Web of Science ®Google Scholar
• Grynberg, K., Ma, F.Y., and Nikolic-Paterson, D.J., 2017. The JNK signaling pathway in renal fibrosis. Frontiers in physiology, 8, 812–829.
   PubMed Web of Science ®Google Scholar
• Hall, J.E., et al., 2015. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circulation research, 116 (6), 991–1006.
   PubMed Web of Science ®Google Scholar
• Hao, C.J., et al., 2012. The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicology and applied pharmacology, 263 (1), 102–110.
   PubMed Web of Science ®Google Scholar
• Hariri, N. and Thibault, L., 2010. High-fat diet-induced obesity in animal models. Nutrition research reviews, 23 (2), 270–299.
   PubMed Web of Science ®Google Scholar
• Harris, R.B.S. and Apolzan, J.W., 2012. Changes in glucose tolerance and leptin responsiveness of rats offered a choice of lard, sucrose, and chow. American journal of physiology. Regulatory, integrative and comparative physiology, 302 (11), R1327–R1339.
   PubMed Web of Science ®Google Scholar
• He, J., et al., 2013. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clinical and experimental nephrology, 17 (4), 488–497.
   PubMed Web of Science ®Google Scholar
• Heijden, R.A.V.D., et al., 2016. Effects of anthocyanin and flavanol compounds on lipid metabolism and adipose tissue associated systemic inflammation in diet-induced obesity. Mediators of inflammation, 2016, 2042107.
   PubMed Web of Science ®Google Scholar
• Henegar, J.R., et al., 2001. Functional and structural changes in the kidney in the early stages of obesity. Journal of the American Society of Nephrology, 12 (6), 1211–1217.
   PubMed Web of Science ®Google Scholar
• Hong, S. and Lu, Y., 2013. Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury. Frontiers in immunology, 4, 13–18.
   PubMed Web of Science ®Google Scholar
• Jéquier, E., 2002. Pathways to obesity. International journal of obesity, 26 (S2), S12–S17.
   Google Scholar
• Kleinert, M., et al., 2018. Animal models of obesity and diabetes mellitus. Nature reviews. Endocrinology, 14 (3), 140–162.
   PubMed Web of Science ®Google Scholar
• Kliem, V., et al., 1996. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney international, 49 (3), 666–678.
   PubMed Web of Science ®Google Scholar
• Knight, S.F., et al., 2008. Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension, 51 (2), 352–359.
   PubMed Web of Science ®Google Scholar
• Komers, R., et al., 2007. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats. Clinical and experimental pharmacology & physiology, 34 (1–2), 36–41.
   PubMed Web of Science ®Google Scholar
• Lan, R., et al., 2012. PTEN loss defines a TGF-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. American journal of physiology-renal physiology, 302 (9), F1210–F1223.
   PubMed Web of Science ®Google Scholar
• Lazar, V., et al., 2019. Gut microbiota, host organism, and diet trialogue in diabetes and obesity. Frontiers in nutrition, 6, 20–21.
   PubMed Web of Science ®Google Scholar
• Linkermann, A., et al., 2014. Regulated cell death in AKI. Journal of the American Society of Nephrology, 25 (12), 2689–2701.
   PubMed Web of Science ®Google Scholar
• Madduma Hewage, S., et al., 2020. Inhibition of inflammatory cytokine expression prevents high-fat diet-induced kidney injury: role of lingonberry supplementation. Frontiers in medicine, 7, 13–80.
   Web of Science ®Google Scholar
• Mccarthy, E.T., et al., 1998. TNF-a increases albumin permeability of isolated rat glomeruli through the generation of superoxide. Journal of the American Society of Nephrology, 9 (3), 433–438.
   PubMed Web of Science ®Google Scholar
• Narumiya, S., Sugimoto, Y., and Ushikubi, F., 1999. Prostanoid receptors: structures, properties, and functions. Physiological Reviews, 79 (4), 1193–1226.
   PubMed Web of Science ®Google Scholar
• Oliveira, D.T.D., et al., 2020. High-sugar diet leads to obesity and metabolic diseases in ad libitum -fed rats irrespective of caloric intake. Archives of endocrinology and metabolism, 64 (1), 71–81.
   PubMed Web of Science ®Google Scholar
• Panchal, S.K. and Brown, L., 2011. Rodent models for metabolic syndrome research. Journal of biomedicine & biotechnology, 2011, 351982.
   PubMed Web of Science ®Google Scholar
• Pekgor, S., et al., 2019. The role of visceral adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients. Metabolic syndrome and related disorders, 17 (5), 296–302.
   PubMed Web of Science ®Google Scholar
• Petersen, M.C. and Shulman, G.I., 2018. Mechanisms of insulin action and insulin resistance. Physiological reviews, 98 (4), 2133–2223.
   PubMed Web of Science ®Google Scholar
• Praga, M. and Morales, E., 2006. Obesity, proteinuria and progression of renal failure. Current opinion in nephrology and hypertension, 15 (5), 481–486.
   PubMed Web of Science ®Google Scholar
• Rodrigues, A.H., et al., 2016. Differential modulation of cytosolic lipases activities in liver and adipose tissue by high-carbohydrate diets. Endocrine, 53 (2), 423–432.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe, B., Johnson, R.J., and Herrera-Acosta, J., 2005. Tubulointerstitial damage and progression of renal failure. Kidney international, 68 (99), S82–S86.
   Google Scholar
• Sharma, M., et al., 2017. Hyperfiltration-associated biomechanical forces in glomerular injury and response: potential role for eicosanoids HHS public access. Prostaglandins & other lipid mediators, 132, 59–68.
   PubMed Web of Science ®Google Scholar
• Silva Junior, G.B.D., et al., 2017. Obesity and kidney disease. Jornal Brasileiro de Nefrologia, 39 (1), 65–69.
   Google Scholar
• Simonson, M.S., 2007. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney international, 71 (9), 846–854.
   PubMed Web of Science ®Google Scholar
• Softic, S., Cohen, D.E., and Kahn, C.R., 2016. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Digestive diseases and sciences, 61 (5), 1282–1293.
   PubMed Web of Science ®Google Scholar
• Tang, J., Yan, H., and Zhuang, S., 2012. Inflammation and oxidative stress in obesity-related glomerulopathy. International journal of nephrology, 2012, 608397.
   PubMedGoogle Scholar
• Taylor, B.A. and Phillips, S.J., 1996. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics, 34 (3), 389–398.
   PubMed Web of Science ®Google Scholar
• Tesauro, M., et al., 2012. Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin. International journal of hypertension, 2012, 943605–943607.
   PubMedGoogle Scholar
• Thomas, G., 1998. Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrology dialysis transplantation, 13 (9), 2216–2226.
   PubMed Web of Science ®Google Scholar
• Toyama, K., et al., 2015. ASK1 is involved in cognitive impairment caused by long-term high-fat diet feeding in mice. Scientific reports, 5 (1), 10844.
   PubMedGoogle Scholar
• Venkatachalam, M.A., et al., 2015. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. Journal of the American Society of Nephrology, 26 (8), 1765–1776.
   PubMed Web of Science ®Google Scholar
• Wahl, P., Ducasa, G.M., and Fornoni, A., 2016. Systemic and renal lipids in kidney disease development and progression. American journal of physiology: renal physiology, 310 (6), F433–F445.
   PubMed Web of Science ®Google Scholar
• Wang, T., et al., 2019. Arachidonic acid metabolism and kidney inflammation. International journal of molecular sciences, 20 (15), 3683.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2018. Obesity and overweight. Geneva, Switzerland: WHO. http://www.who.int/mediacentre/factsheets/fs311/en/#.WsT7lyqxzHQ.mendeley.
   Google Scholar
• Wu, Y., et al., 2006. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology, 147 (1), 44–50.
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., et al., 2017. High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. Journal of the American Society of Nephrology, 28 (5), 1534–1551.
   PubMed Web of Science ®Google Scholar
• Yu, J., et al., 2019. High-mobility group nucleosome-binding protein 1 mediates renal fibrosis correlating with macrophages accumulation and epithelial-to-mesenchymal transition in diabetic nephropathy mice model. Kidney & blood pressure research, 44 (3), 331–343.
   PubMed Web of Science ®Google Scholar
• Zhong, J., Yang, H.-C., and Fogo, A.B., 2017. A perspective on chronic kidney disease progression. American journal of physiology. Renal physiology, 312 (3), F375–F384.
   PubMed Web of Science ®Google Scholar